Previous Article
Liminal BioSciences Announces Signature of a Share Purchase Agreement for Sale of Remaining Plasma-derived Business with Kedrion
Liminal BioSciences Announces Signature of a Share Purchase Agreement for Sale of Remaining Plasma-derived Business with Kedrion

Next Flipbook
Quarterly Report Q1 2021
Quarterly Report Q1 2021

Go to Liminal BioSciences Q2 2021 Results Conference Call

View Now